• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Changing from NAFLD to MASLD: The new definition can more accurately identify individuals at higher risk for diabetes.

作者信息

He Linfeng, Zheng Wenbin, Qiu Kangli, Kong Wen, Zeng Tianshu

机构信息

Department of Endocrinology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China; Diabetes and Metabolic Disease Clinical Research Center of Hubei Province, China; Hubei Key Laboratory of Metabolic Abnormalities and Vascular Aging, China; Hubei Branch of National Center for Clinical Medical Research of Metabolic Diseases, China.

Department of Endocrinology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China; Diabetes and Metabolic Disease Clinical Research Center of Hubei Province, China; Hubei Key Laboratory of Metabolic Abnormalities and Vascular Aging, China; Hubei Branch of National Center for Clinical Medical Research of Metabolic Diseases, China.

出版信息

J Hepatol. 2024 Feb;80(2):e85-e87. doi: 10.1016/j.jhep.2023.09.035. Epub 2023 Oct 10.

DOI:10.1016/j.jhep.2023.09.035
PMID:37827469
Abstract
摘要

相似文献

1
Changing from NAFLD to MASLD: The new definition can more accurately identify individuals at higher risk for diabetes.从非酒精性脂肪性肝病转变为代谢功能障碍相关脂肪性肝病：新定义能够更准确地识别出糖尿病风险较高的个体。
J Hepatol. 2024 Feb;80(2):e85-e87. doi: 10.1016/j.jhep.2023.09.035. Epub 2023 Oct 10.
2
[Non-alcoholic fatty liver disease (NAFLD)].非酒精性脂肪性肝病（NAFLD）
Dtsch Med Wochenschr. 2015 Jul;140(14):1051-5. doi: 10.1055/s-0041-102787. Epub 2015 Jul 16.
3
Changing from NAFLD to MASLD: Similar cumulative incidence of reflux esophagitis between NAFLD and MASLD.从非酒精性脂肪性肝病转变为代谢功能障碍相关脂肪性肝病：非酒精性脂肪性肝病和代谢功能障碍相关脂肪性肝病之间反流性食管炎的累积发病率相似。
Clin Mol Hepatol. 2024 Jan;30(1):121-123. doi: 10.3350/cmh.2023.0437. Epub 2023 Dec 4.
4
Clinical profiles and mortality rates are similar for metabolic dysfunction-associated steatotic liver disease and non-alcoholic fatty liver disease.代谢相关脂肪性肝病和非酒精性脂肪性肝病的临床特征和病死率相似。
J Hepatol. 2024 May;80(5):694-701. doi: 10.1016/j.jhep.2024.01.014. Epub 2024 Jan 27.
5
Prevalence and staging of non-alcoholic fatty liver disease among patients with heart failure with preserved ejection fraction.射血分数保留的心力衰竭患者中非酒精性脂肪性肝病的患病率和分期。
Sci Rep. 2020 Jul 24;10(1):12440. doi: 10.1038/s41598-020-69013-y.
6
Can we use old NAFLD data under the new MASLD definition?在新的代谢相关脂肪性肝病（MASLD）定义下，我们能否使用旧的非酒精性脂肪性肝病（NAFLD）数据？
J Hepatol. 2024 Feb;80(2):e54-e56. doi: 10.1016/j.jhep.2023.07.021. Epub 2023 Aug 2.
7
From NAFLD to MASLD: When metabolic comorbidity matters.从非酒精性脂肪性肝病到代谢相关性脂肪性肝病：当代谢合并症起重要作用时。
Ann Hepatol. 2024 Mar-Apr;29(2):101281. doi: 10.1016/j.aohep.2023.101281. Epub 2023 Dec 21.
8
Synergistic increase in cardiovascular risk in diabetes mellitus with nonalcoholic fatty liver disease: a meta-analysis.糖尿病合并非酒精性脂肪性肝病患者心血管风险的协同增加：一项荟萃分析。
Eur J Gastroenterol Hepatol. 2018 Jun;30(6):631-636. doi: 10.1097/MEG.0000000000001075.
9
Reply to: "From NAFLD to MASLD: Promise and pitfalls of a new definition": EASL, AASLD and ALEH stand united to advance the field of steatotic liver disease.回复：“从非酒精性脂肪性肝病到代谢相关脂肪性肝病：新定义的前景与陷阱”：欧洲肝脏研究学会（EASL）、美国肝病研究学会（AASLD）和阿卜杜勒阿齐兹国王肝脏研究与移植中心（ALEH）联合起来推动脂肪性肝病领域的发展。
J Hepatol. 2024 Jul;81(1):e20-e21. doi: 10.1016/j.jhep.2023.10.008. Epub 2023 Dec 19.
10
MASLD vs. NAFLD: A better definition for children with obesity at higher risk of kidney damage.代谢功能障碍相关脂肪性肝病与非酒精性脂肪性肝病：对有更高肾脏损伤风险的肥胖儿童的更好定义。
J Hepatol. 2024 Feb;80(2):e87-e89. doi: 10.1016/j.jhep.2023.10.021. Epub 2023 Oct 27.

引用本文的文献

1
Association between polycyclic aromatic hydrocarbons exposure and metabolic dysfunction-associated steatotic liver disease in US adults.美国成年人中多环芳烃暴露与代谢功能障碍相关脂肪性肝病之间的关联。
Front Public Health. 2025 Jun 11;13:1540357. doi: 10.3389/fpubh.2025.1540357. eCollection 2025.
2
Cooked Bean ( L.) Consumption Alters Bile Acid Metabolism in a Mouse Model of Diet-Induced Metabolic Dysfunction: Proof-of-Concept Investigation.食用煮熟的菜豆（L.）可改变饮食诱导的代谢功能障碍小鼠模型中的胆汁酸代谢：概念验证研究。
Nutrients. 2025 May 28;17(11):1827. doi: 10.3390/nu17111827.
3
Combination therapy with vitamin E and ertugliflozin in patients with non-alcoholic fatty liver disease and type 2 diabetes mellitus: a randomized clinical trial.
维生素E与依鲁格列净联合治疗非酒精性脂肪性肝病合并2型糖尿病患者：一项随机临床试验。
Ir J Med Sci. 2025 Apr 9. doi: 10.1007/s11845-025-03945-0.
4
Associations of the Intake of Individual and Multiple Flavonoids with Metabolic Dysfunction Associated Steatotic Liver Disease in the United States.美国个体及多种类黄酮摄入量与代谢功能障碍相关脂肪性肝病的关联
Nutrients. 2025 Jan 7;17(2):205. doi: 10.3390/nu17020205.
5
Comparing diabetes prediction based on metabolic dysfunction-associated steatotic liver disease and nonalcoholic fatty liver disease: the ELSA-Brasil study.比较基于代谢功能障碍相关脂肪性肝病和非酒精性脂肪性肝病的糖尿病预测：ELSA-Brasil 研究。
Cad Saude Publica. 2024 Nov 25;40(11):e00009924. doi: 10.1590/0102-311XEN009924. eCollection 2024.
6
The effect of ertugliflozin in patients with nonalcoholic fatty liver disease associated with type 2 diabetes mellitus: A randomized controlled trial.在伴有 2 型糖尿病的非酒精性脂肪性肝病患者中，厄格列净的疗效：一项随机对照试验。
Medicine (Baltimore). 2024 Nov 8;103(45):e40356. doi: 10.1097/MD.0000000000040356.
7
Metabolic Dysfunction-Associated Steatotic Liver Disease in Patients with Inflammatory Bowel Diseases: A Pilot Study.炎症性肠病患者的代谢功能障碍相关脂肪性肝病：一项初步研究。
Life (Basel). 2024 Sep 25;14(10):1226. doi: 10.3390/life14101226.
8
Targeting hepatic macrophages for non-alcoholic fatty liver disease therapy.以肝脏巨噬细胞为靶点治疗非酒精性脂肪性肝病
Front Cell Dev Biol. 2024 Sep 5;12:1444198. doi: 10.3389/fcell.2024.1444198. eCollection 2024.
9
Environmental toxicants modulate disease severity in pediatric metabolic dysfunction-associated steatohepatitis.环境毒物可调节儿童代谢功能障碍相关脂肪性肝炎的疾病严重程度。
J Pediatr Gastroenterol Nutr. 2024 Nov;79(5):943-953. doi: 10.1002/jpn3.12346. Epub 2024 Sep 16.
10
Association of healthy lifestyles with risk of all-cause and cause-specific mortality among individuals with metabolic dysfunction-associated steatotic liver disease: results from the DFTJ cohort.代谢相关脂肪性肝病患者健康生活方式与全因和特定原因死亡率的相关性：来自 DFTJ 队列的研究结果。
Ann Med. 2024 Dec;56(1):2398724. doi: 10.1080/07853890.2024.2398724. Epub 2024 Sep 9.